ES8502088A1 - Un procedimiento para preparar un compuesto de nitrato piridilalquilico - Google Patents

Un procedimiento para preparar un compuesto de nitrato piridilalquilico

Info

Publication number
ES8502088A1
ES8502088A1 ES524375A ES524375A ES8502088A1 ES 8502088 A1 ES8502088 A1 ES 8502088A1 ES 524375 A ES524375 A ES 524375A ES 524375 A ES524375 A ES 524375A ES 8502088 A1 ES8502088 A1 ES 8502088A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical composition
same
nitrate compound
alkyl nitrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524375A
Other languages
English (en)
Other versions
ES524375A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES524375A0 publication Critical patent/ES524375A0/es
Publication of ES8502088A1 publication Critical patent/ES8502088A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UN COMPUESTO DE NITRATO PIRIDILALQUILICO, DE FORMULA GENERAL (I), EN LA QUE R ES HIDROGENO, ALQUILO INFERIOR O HALOGENO; Y R Y R SON HIDROGENO O HALOGENO, Y SUS SALES ACEPTABLES EN FARMACIA.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II) O SUS SALES, CON UN AGENTE DE NITRACION.DE APLICACION EN LA PREPARACION DE COMPOSICIONES FARMACEUTICAS UTILIZADAS EN EL TRATAMIENTO TERAPEUTICO DE DESORDENES CARDIOVASCULARES EN SERES HUMANOS.
ES524375A 1982-07-26 1983-07-22 Un procedimiento para preparar un compuesto de nitrato piridilalquilico Expired ES8502088A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8221592 1982-07-26

Publications (2)

Publication Number Publication Date
ES524375A0 ES524375A0 (es) 1984-12-16
ES8502088A1 true ES8502088A1 (es) 1984-12-16

Family

ID=10531922

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524375A Expired ES8502088A1 (es) 1982-07-26 1983-07-22 Un procedimiento para preparar un compuesto de nitrato piridilalquilico

Country Status (17)

Country Link
US (2) US4540701A (es)
EP (1) EP0100081B1 (es)
JP (1) JPS5951263A (es)
KR (1) KR900005470B1 (es)
AT (1) ATE40948T1 (es)
AU (1) AU565791B2 (es)
CA (1) CA1216850A (es)
DE (1) DE3379255D1 (es)
DK (1) DK311683A (es)
ES (1) ES8502088A1 (es)
FI (1) FI832490L (es)
GR (1) GR78629B (es)
HU (1) HU190497B (es)
NO (1) NO832700L (es)
PH (1) PH18083A (es)
SU (1) SU1189337A3 (es)
ZA (1) ZA835048B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPS6215A (ja) * 1985-02-26 1987-01-06 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンまたはそのβ−シクロデキストリン包接化合物含有持続性製剤
ZA885069B (en) * 1987-07-24 1989-03-29 Fujisawa Pharmaceutical Co Sustained-release percutaneous preparations
JPH02167279A (ja) * 1988-09-30 1990-06-27 Taisho Pharmaceut Co Ltd アポビンカミン酸誘導体
US5047543A (en) * 1988-11-24 1991-09-10 Taisho Pharmaceutical Co., Ltd. 1,4-dihydropyridine derivatives
CN106318877A (zh) * 2016-08-29 2017-01-11 刘翔 一种从茯砖茶中分离、纯化冠突散囊菌及其液态培养方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275642A (en) * 1962-04-26 1966-09-27 Bard Pharmaceutical Inc 3-pyridine carbinol nitrate and its preparation
US3689494A (en) * 1971-03-31 1972-09-05 William R J Simpson N-pyridinealkyl-alkanolamine nitrates

Also Published As

Publication number Publication date
ATE40948T1 (de) 1989-03-15
FI832490A0 (fi) 1983-07-07
FI832490L (fi) 1984-01-27
DK311683A (da) 1984-01-27
DK311683D0 (da) 1983-07-05
NO832700L (no) 1984-02-06
US4613608A (en) 1986-09-23
EP0100081B1 (en) 1989-03-01
CA1216850A (en) 1987-01-20
KR900005470B1 (ko) 1990-07-30
EP0100081A2 (en) 1984-02-08
DE3379255D1 (en) 1989-04-06
SU1189337A3 (ru) 1985-10-30
AU1663583A (en) 1984-02-02
HU190497B (en) 1986-09-29
KR840005426A (ko) 1984-11-12
JPS6350343B2 (es) 1988-10-07
ES524375A0 (es) 1984-12-16
EP0100081A3 (en) 1985-05-02
AU565791B2 (en) 1987-10-01
JPS5951263A (ja) 1984-03-24
PH18083A (en) 1985-03-18
ZA835048B (en) 1984-03-28
US4540701A (en) 1985-09-10
GR78629B (es) 1984-09-27

Similar Documents

Publication Publication Date Title
MY101891A (en) Novel carbostyril derivative and process for preparing same.
ES8706664A1 (es) Procedimiento para preparar compuestos carbostirilicos
HUT37128A (en) Process for the production of dihydropyridazinone-derivatives, as well as of pharmaceutical preparations containing these derivatives as agent
ES8306160A1 (es) "procedimiento para preparar un nuevo compuesto de cefem".
DE3279103D1 (en) New cephem compounds, processes for preparation thereof and pharmaceutical composition containing them
AU589427B2 (en) Pyridonecarboxylic acid derivatives and process for their preparation
ES8301967A1 (es) Procedimiento de preparar compuestos carbostirilicos.
MY100095A (en) 2-oxo-imidazolidine compounds, a process for preparing the same and a pharmaceutical composition.
ES8506730A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
HUT40101A (en) Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
GR3001506T3 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
ES8307825A1 (es) "un procedimiento para preparar un compuesto de cefem".
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
ES8502088A1 (es) Un procedimiento para preparar un compuesto de nitrato piridilalquilico
ES8400488A1 (es) Un procedimiento para la preparacion de la sustancia f.r.-48756 acido 1-(6-amino-9-h-purin-9-il)-1,3-didedoxo-3-(o-metil l-tirosilamino)-b-d-ribofuranuronico.
ES8303398A1 (es) Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida.
ES2000907A6 (es) Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
GR3003126T3 (en) Quinolinecarboxylic acid derivatives, a composition comprising the same, process for preparing the same, and the use of the same for the manufacture of medicaments
GB1465783A (en) Pyrrolyl compounds and processes for their manufacture
ES8201531A1 (es) Procedimiento de preparar alcoxi propanolaminas
ES8502094A1 (es) Un procedimiento para la preparacion de derivados de tetrahidroisoquinolina.
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
ES8504820A1 (es) Un procedimiento para preparar compuestos de cefem que tienen grupos tiadiazol c isotiazol.